Conditions: Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma
Interventions: Procedure: Elastography; Procedure: Magnetic Resonance Imaging; Procedure: Photoacoustic Imaging; Procedure: Ultrasound Imaging; Drug: Pembrolizumab; Drug: Carboplatin; Drug: Paclitaxel; Drug: Doxorubicin; Drug: Cyclophosphamide
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Interventions: Procedure: Elastography; Procedure: Magnetic Resonance Imaging; Procedure: Photoacoustic Imaging; Procedure: Ultrasound Imaging; Drug: Pembrolizumab; Drug: Carboplatin; Drug: Paclitaxel; Drug: Doxorubicin; Drug: Cyclophosphamide
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
